Absolute Neutrophil Count in the Peripheral Blood Predicts Prognosis in Lung Cancer Patients Treated with Anlotinib

PURPOSE: Anlotinib is a multi-targeted tyrosine kinase inhibitor that inhibits tumor angiogenesis and cell proliferation. It is widely used as a third-line therapy for lung cancer. However, reliable prognostic biomarkers for predicting the efficacy of anlotinib are lacking. We conducted a retrospect...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Rong, Lu, Fang-Ying, Liu, Bing, Huang, Jingwen, Zhou, Min, Dai, Ranran, Guo, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8106457/
https://www.ncbi.nlm.nih.gov/pubmed/33976572
http://dx.doi.org/10.2147/CMAR.S307368

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8106457/
https://www.ncbi.nlm.nih.gov/pubmed/33976572
http://dx.doi.org/10.2147/CMAR.S307368

Ejemplares similares